| 000 | 01216 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250515170352.0 | ||
| 264 | 0 | _c20090817 | |
| 008 | 200908s 0 0 eng d | ||
| 022 | _a1365-2346 | ||
| 024 | 7 |
_a10.1097/EJA.0b013e32831bc67a _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChurch, Hannah L | |
| 245 | 0 | 0 |
_aIs the decreasing availability of vecuronium and pancuronium putting patients at risk? _h[electronic resource] |
| 260 |
_bEuropean journal of anaesthesiology _cApr 2009 |
||
| 300 |
_a347-8 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 |
_aAnaphylaxis _xprevention & control |
| 650 | 0 | 4 |
_aCross Reactions _ximmunology |
| 650 | 0 | 4 |
_aDrug Hypersensitivity _xetiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeuromuscular Blocking Agents _xadverse effects |
| 650 | 0 | 4 |
_aNeuromuscular Nondepolarizing Agents _xsupply & distribution |
| 650 | 0 | 4 |
_aPancuronium _xsupply & distribution |
| 650 | 0 | 4 |
_aVecuronium Bromide _xsupply & distribution |
| 700 | 1 | _aKong, K L | |
| 700 | 1 | _aNorth, Jonathan | |
| 773 | 0 |
_tEuropean journal of anaesthesiology _gvol. 26 _gno. 4 _gp. 347-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/EJA.0b013e32831bc67a _zAvailable from publisher's website |
| 999 |
_c18831715 _d18831715 |
||